Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

Affinium Pharmaceuticals Inc.

Affinium Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovery and development of novel anti-infective medicines. The Affinium FASII antibacterial programs constitute a new antibiotic franchise with the potential for multiple products targeting the FASII pathway. These programs include a broad base of long-term intellectual property: issued and pending composition of matter patents on potent orally available small molecule inhibitors of a new class of antibiotics with a unique mechanism of action, targeting an underexploited pathway. Affinium's major investors include SV Life Science Advisors LLC, Genesys Capital Management, Forward Ventures, and Ontario Capital Growth Corporation. *


Period Start 2003-01-01 renamed
  Predecessor Integrative Proteomics Inc.
Product Industry proteomics
Region Region Toronto, ON
  Country Canada
  Street 200 Front Street West
Suite 3004, B.O. Box 31
  City M5V 3K2 Toronto, ON
  Tel +1-416-645-6613
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for »About Section«: 
Record changed: 2023-07-10


Picture Bionter Seeing Things witzh EVE the Particle Counter 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px

» top